Quantum Biopharma Debt-to-Assets Ratio Growth & History (QNTM)

Quantum Biopharma's debt-to-assets ratio was 0.13 for fiscal 2025.

View full Quantum Biopharma company overview

Quantum Biopharma annual debt-to-assets ratio history

Quantum Biopharma annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.130.09+220.02%
20242024-12-310.040.04+1676.93%
20232023-12-310.00−0.00−60.65%
20222022-12-310.010.00+38.58%
20212021-12-310.000.00+35.12%
20202020-12-310.00−0.00−15.01%
20192019-12-310.00

Quantum Biopharma debt-to-assets ratio trends

Over the last five fiscal years, Quantum Biopharma's debt-to-assets ratio increased from 0.00 to 0.13, a change of 0.12. The latest reported quarter, Q2 2026, shows 0.07.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Quantum Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about QNTM yet. Start the conversation.

Write the first post